PRENW
Prenetics Holding Company LimitedKey Statistics
About Prenetics Holding Company Limited
Prenetics Holding Company Limited is an innovative healthcare technology company that specializes in genetic testing and digital health solutions aimed at improving health outcomes. By harnessing advanced technologies and comprehensive data analytics, Prenetics delivers a wide range of genetic screening and diagnostic services that empower personalized medicine and actionable health insights. With the increasing demand for precision health solutions, Prenetics is well-positioned to capitalize on emerging opportunities within the dynamic, data-driven healthcare ecosystem, making it an attractive prospect for institutional investors seeking growth in the health tech sector.
Fundamentals
| Revenue (TTM) | $120.07M |
| Gross Profit (TTM) | $66.47M |
| EBITDA | $-40.82M |
| Operating Margin | -24.70% |
| Return on Equity | -40.80% |
| Return on Assets | -13.50% |
| Revenue/Share (TTM) | $7.98 |
| Book Value | $9.76 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 107.70% |
| Shares Outstanding | 0 |
| Float | $12.63M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
Volatility is currently expanding
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on PRENW and any ticker you trade — then tracks every position and per-strategy win rate.